Target Site Pharmacokinetics of Doripenem After a Single Dose of 500mg in Healthy Volunteers - a Pilot Study.

Trial Profile

Target Site Pharmacokinetics of Doripenem After a Single Dose of 500mg in Healthy Volunteers - a Pilot Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2011

At a glance

  • Drugs Doripenem (Primary)
  • Indications Gram-negative infections; Gram-positive infections; Intra-abdominal infections; Nosocomial pneumonia; Paediatric infections; Respiratory tract infections; Urinary tract infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top